Even before COVID-19 ravaged the medical workforce, physicians, nurses, and other health workers were at increased risk for burnout and depression. Although these professionals are equipped to manage…
Occupational therapists and occupational therapy (OT) assistants at NYU Langone Health are finding themselves working on the front line of this pandemic to help patients recover from COVID-19.…
NEW YORK (Reuters Health) – In patients with high-risk acute coronary syndromes (ACS) without ST-segment elevation, delaying intervention until the next working day does not appear to pose…
NEW YORK (Reuters Health) – Onset of hyperthermia several days after acute ischemic stroke is strongly associated with greater morbidity and mortality at 3 months, investigators report. A…
NEW YORK (Reuters Health) – In patients with acute coronary syndromes (ACS), ticagrelor appears to be more effective than clopidogrel in reducing the incidence of death from vascular…
NEW YORK (Reuters Health) – The risk of venous thromboembolism (VTE) conferred by oral contraceptives appears to be lowest with the older standbys: contraceptives containing levonorgestrel, progestogen-only pills,…
NEW YORK (Reuters Health) – A new generation of sensitive assays for measuring cardiac troponin I could enhance the diagnostic accuracy for acute myocardial infarction (MI), even early…
NEW YORK (Reuters Health) – Environmental exposure to tobacco smoke – a known risk factor for myocardial infarction and other acute coronary syndromes (ACS) – can also worsen…
NEW YORK (Reuters Health) – Stroke is uncommon after percutaneous coronary intervention (PCI), according to a study of the American College of Cardiology National Cardiovascular Data Registry (NCDR).…
NEW YORK (Reuters Health) – Patients with high-risk esophageal varices treated with the beta-blocker carvedilol had lower rates of first bleeding episodes than patients treated with variceal band…
NEW YORK (Reuters Health) – Neoadjuvant hormonal therapy for prostate cancer may increase the risk of death in men with coronary artery disease-induced heart failure or myocardial infarction…
NEW YORK (Reuters Health) – Long-term, high-dose ursodeoxycholic acid (UDCA) should not be used for treatment of primary sclerosing cholangitis because of the increased risk of severe adverse…
